Original article - Blood Transfusion

G Fratellanza et al.References1) Krunicki TS, Newman PJ The molecular immunology ofhuman platelet proteins. Blood 1992; 80: 1386-404.2) Newman PJ, Derbes RS, Aster RH The human plateletalloantigens, Pl A1 and Pl A2 are associated with a leucin 33/proline 33 amino acid polymorphism in membraneglycoproteins IIIa, and are distinguishable by DNA typing. JClin Invest 1989; 83: 1778-81.3) Newman PJ, Mc Farland JG, Aster RH AlloimmuneThrombocytopenia. In: Loscalzo J, Schafer Al, editors.Thrombosis and Hemorrhage. Boston, Blackwell ScientificPublications 1994. p. 529-43.4) Mc Farlands JG, Aster RH, Bussel JB, et al. Prenataldiagnosis of neonatal alloimmune thrombocytopenia usingallele-specific oligonucleotide probes. Blood 1991; 78: 2276-82.5) Unkelbach K, Kalb R, Santoso S, et al. Genomic RFLP typingof human platelet alloantigens Zw (PlA), Ko, Bak and Br(HPA-1,2,3,5). Br J Haematol 1995; 89: 169-76.6) Metcalfe P, Waters AH. HPA 1 typing by PCR amplificationwith sequence-specific primers (PCR-SSP): a rapid andsimple technique. Br J Haematol 1993; 85: 227-9.7) Lyou JY, Chen YJ, Hu HY, et al. PCR with sequence-specificprimer-based simultaneous genotyping of human plateletantigen-1 to -13w. Transfusion 2002; 42: 1089-95.8) Jones DC, Bunce M, Fuggle SV, et al. Human plateletalloantigens (HPAs): PCR-SSP genotyping of a UKpopulation for 15 HPA alleles. Eur J Immunogenet 2003; 30:415-9.9) Fujiwara K, Tokunaga K, Wang L, et al. DNA-based typingof human platelet antigen systems by polymerase chainreaction single-strand conformation polymorphism method.Vox Sang 1995; 69: 347-51.10) Mackey K, Steinkamp A, Chomczynski P. DNA extractionfrom small blood volumes and the processing of celluloseblood cards for use in PCR. Mol Biotechnol 1998; 9: 1-5.11) Simsek S, Faber NM, Bleeker PM, et al. Determination ofhuman platelet antigens in the Dutch population byimmunophenotyping and DNA (allele-specific restrictionenzyme) analysis. Blood 1993; 81: 835-40.12) Kim HO, Jin Y, Kickler TS, et al. Gene frequencies of the fivemajor human platelet antigens in African American, white,and Korean populations. Transfusion 1995; 35: 863-7.13) Kekomaki S, Partanen I, Kekomaki R. Platelet alloantigenHPA 1, 2, 3, 5 and 6b in Finns. Transf Med 1995; 5: 193.14) Tanaka S, Ohnoki S, Shibata H, et al. Gene frequencies ofhuman platelet antigens on glycoprotein IIIa in Japanese.Transfusion 1996; 36: 813-7.15) Tanaka S, Tanins A, Nagan N, et al. Genotype frequencies ofthe human platelet antigen Ca/Tu in Japanese determined bya PCR-RFLP method. Vox Sang 1995; 70: 40-4.16) Riner AP, Teramura G. A modified PCR-RFLP genotypingmethod demonstrates the presence of the HPA 4b plateletalloantigen in a North American Indian population.Immunohematol 1997; 13: 37-43.17) Warkentin TE, Smith JW. The alloimmune thrombocytopenicsyndromes. Transf Med Rev 1997; 11: 296-307.18) Kiefel V, Santoso S, Weisheit M, et al. Monoclonal antibodyspecific immobilization of platelet antigens (MAIPA): a newtool for the identification of platelet reactive antibodies. Blood1987; 70: 1722-6.19) Kupatawintu P, Nathalang O, O-Charoen R, et al. Genefrequencies of the HPA-1 to 6 and Gov human plateletantigens in Thai blood donors. Immunohematol 2005; 21: 5-9.20) Rachel JM, Summers TC, Sinor LT, et al. Use of a solidphase red blood cell adherence method for pre-transfusionplatelet compatibility testing. Am J Clin Pathol 1988; 90:63-8.21) Ohto H, Miura S, Ariga H, et al. The natural history ofmaternal immunization against foetal platelet alloantigens.Transfus Med 2004; 14: 399-408.22) Breamdam S, Frepi MB, De Geey SR. Evaluation of solidphase enzyme immunoassay and comparison with the indirectimmunofluorescence. Am J Cl Pathol 1998; 109: 190-5.23) Dreyfus M, Kaplan C, Verdy E, et al. Frequency of immunethrombocytopenic in newborns: a prospective study. Blood1997; 89: 4402-6.24) Verran J, Grey D, Bennett J, et al. HPA-1,3,5 genotyping toestablish a typed platelet donor panel. Pathology 2000; 32:89-93.230Blood Transfus 2005; 3: 222-30